Indegene Toekomstige groei
Future criteriumcontroles 3/6
Indegene is forecast to grow earnings and revenue by 18.4% and 11.9% per annum respectively. EPS is expected to grow by 17% per annum. Return on equity is forecast to be 17.4% in 3 years.
Belangrijke informatie
18.4%
Groei van de winst
17.0%
Groei van de winst per aandeel
| Life Sciences winstgroei | 21.4% |
| Inkomstengroei | 11.9% |
| Toekomstig rendement op eigen vermogen | 17.4% |
| Dekking van analisten | Low |
| Laatst bijgewerkt | 30 Oct 2024 |
Recente toekomstige groei-updates
Geen updates
Recent updates
Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 3/31/2027 | 36,079 | 5,787 | 5,222 | 5,704 | 5 |
| 3/31/2026 | 31,685 | 4,932 | 4,431 | 4,861 | 5 |
| 3/31/2025 | 28,034 | 3,971 | 3,329 | 4,150 | 5 |
| 9/30/2024 | 27,097 | 3,730 | 4,302 | 4,377 | N/A |
| 6/30/2024 | 26,586 | 3,560 | N/A | N/A | N/A |
| 3/31/2024 | 25,896 | 3,367 | 4,970 | 5,077 | N/A |
| 12/31/2023 | 25,489 | 2,907 | 3,871 | 4,100 | N/A |
| 6/30/2023 | 23,927 | 2,487 | N/A | N/A | N/A |
| 3/31/2023 | 23,061 | 2,661 | 1,114 | 1,302 | N/A |
| 3/31/2022 | 16,646 | 1,648 | 2,723 | 2,970 | N/A |
| 3/31/2021 | 9,806 | 1,857 | 1,514 | 1,720 | N/A |
| 3/31/2020 | 6,436 | 558 | 162 | 223 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: INDGN's forecast earnings growth (18.4% per year) is above the savings rate (6.7%).
Winst versus markt: INDGN's earnings (18.4% per year) are forecast to grow faster than the Indian market (18.1% per year).
Hoge groeiwinsten: INDGN's earnings are forecast to grow, but not significantly.
Omzet versus markt: INDGN's revenue (11.9% per year) is forecast to grow faster than the Indian market (10.2% per year).
Hoge groei-inkomsten: INDGN's revenue (11.9% per year) is forecast to grow slower than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: INDGN's Return on Equity is forecast to be low in 3 years time (17.4%).